Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
96 hedge funds and large institutions have $13.9M invested in Vaxart in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 30 reducing their positions, and 23 closing their positions.
1,340% more call options, than puts
Call options by funds: $216K | Put options by funds: $15K
9.18% less ownership
Funds ownership: 21.34% → 12.16% (-9.2%)
14% less funds holding
Funds holding: 111 → 96 (-15)
34% less capital invested
Capital invested by funds: $21.1M → $13.9M (-$7.19M)
37% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 30
65% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$205K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$166K |
| 3 |
PPP
Private Portfolio Partners
Paramus,
New Jersey
|
+$84.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.5K |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$30.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$4.01M |
| 2 |
Renaissance Technologies
New York
|
-$576K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$566K |
| 4 |
Millennium Management
New York
|
-$427K |
| 5 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
-$365K |
VXRT Hedge Fund Activity: Q3 2023 in Review
96 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2023, worth a combined $13.9M — down 34% from $21.1M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of VXRT and 8 opened new positions — a net loss of 15 holders — while 30 trimmed existing stakes and 19 added.
The largest buyer was GSA Capital Partners, adding an estimated $205K. The largest seller was Cantor Fitzgerald, cutting an estimated $4.01M.
- 96 institutional investors held Vaxart (VXRT) as of Q3 2023, down from 111 in Q2 2023.
- Funds reported $13.9M of Vaxart stock for Q3 2023, down 34% quarter-over-quarter.
- 8 funds opened new Vaxart positions in Q3 2023 and 23 closed out, a net change of -15 holders.
- The largest Vaxart buyer in Q3 2023 was GSA Capital Partners, an estimated $205K added.
- The largest Vaxart seller in Q3 2023 was Cantor Fitzgerald, an estimated $4.01M sold.
Based on aggregated 13F filings for Q3 2023.